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ApoptosisEukaryotic translation initiation factor 3 is composed of 13 subunits (eIF3a through eIF3m) and
plays an essential role in translation. During apoptosis, several caspases rapidly down-regulate pro-
tein synthesis by cleaving eIF4G, -4B, -3j, and -2a. In this study, we found that the activation of casp-
ases by cisplatin in T24 cells induces the cleavage of subunit G of the eIF3 complex (eIF3g). The
cleavage site (SLRD220G) was identiﬁed, and we found that the cleaved N-terminus was translocated
to the nucleus, activating caspase-3, and that it also showed a strong DNase activity. These data dem-
onstrate the important roles of eIF3g in the translation initiation machinery and in DNA degradation
during apoptosis.
 2013 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Gene expression is regulated at both transcriptional and trans-
lational levels, and its deregulation results in abnormal gene
expression or apoptosis. The efﬁciency of translation initiation
determines the rate of protein synthesis involves complex interac-
tions between many translation initiation factors (eIFs) and RNA
molecules, and requires protein interactions between individual
eIF subunits and ribosomes. Among the 11 eIFs, eukaryotic transla-
tion initiation factor 3 (eIF3) is the most complex factor and plays a
central role in the initiation pathway [1–4]. eIF3 binds directly to
the 40S ribosomal subunit and promotes the binding of Met-tRNA
and mRNA. Additionally, eIF3 binds directly to eIF1, eIF4B, eIF4G,
and eIF5 through its individual subunits. In mammalian cells, theeIF3 complex has a molecular weight of approximately 700 kDa
and consists of 13 multi-subunits: eIF3a (p170), -b (p116),
-c (p110), -d (p66), -e (p48), -f (p47), -g (p44), -h (p40), -i (p36),
-j (p35), -k (p28), -l (p67), and -m (GA17) [5–7]. Among them, eIF3a
(Tif32p in yeast S accharomyces cerevisiae), eIF3b (Nip1p), eIF3c
(Prt1p), eIF3g (Tif35p), and eIF3i (Tif34p) comprise the eIF3 core
complex [8] and are conserved in yeast and mammalian cells.
Apoptosis is generally associated with the collapse of the pro-
tein translation machinery, which is mediated by caspase activa-
tion [9]. When executioner caspases are activated by initiator
caspases or other signals that do not depend on a caspase cascade,
these enzymes cleave critical proteins that are required for the
maintenance of cellular homeostasis, including the translation ini-
tiation machinery. The inhibition of translation is accompanied by
the modiﬁcation of translation factors, such as the phosphorylation
of eIF2a and the caspase-mediated cleavage of initiation factors
eIF4G [10–12], eIF4B [13], eIF4E-binding protein (eIF4E-BP1) [13],
eIF2a [14], and eIF3j [13]. eIF4G is cleaved by caspases at a region
between the eIF4E and eIF3 binding sites, causing the loss of the
bridging function for the eIFs and mRNA circularization. eIF4B,
eIF3j, and eIF2a are also cleaved by caspase-3 during serum starva-
tion or tumor necrosis factor a (TNF-a) treatment.
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which is capable of translocating frommitochondria to the nucleus
during apoptosis, inhibits protein synthesis by interacting with
eIF3g [15]. In this study, we demonstrate that eIF3g is cleaved by
caspases-3 and -7 during apoptosis and that cleaved-eIF3g demon-
strates DNase activity.
2. Materials and methods
2.1. Cell culture and reagents
T24 bladder carcinoma cells were cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM; Gibco-BRL, NY, USA) supple-
mented with 10% heat-inactivated fetal bovine serum (FBS).
Staurosporine (STS; Calbiochem, CA, USA) and cisplatin (CDDP,
cis-diaminedichloroplatinum (II); Sigma, MO, USA) were used for
apoptosis. For caspase inhibition, z-DEVD-fmk (acetyl Asp-
Glu-Val-Asp 7-amido-4-methylcoumarin, Calbiochem), z-IETD-
fmk, z-LEHD-fmk, and z-VAD-fml (Transduction Laboratories, KY,
USA) were utilized.
2.2. Antibodies (Abs)
Goat anti-eIF3 and rabbit anti-eIF3g Abs were kindly provided
by Drs. John W. Hershey (University of California, CA, USA) and
Tang K. Tang (Institute of Biomedical Sciences, Taiwan), respec-
tively. In addition, we generated an anti-eIF3g Ab from Balb/c mice
that were immunized with the puriﬁed recombinant eIF3g-1–229C
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Fig. 1. Cleavage of eIF3g by caspase-3 and -7. (A) T24 cells were treated with either CDDP
followed by immunoblotting. Arrows, eIF3 subunits. (B) pcDNA3-eIF3g was in vitro trans
reticulocyte mixture at 37 C for 3 h. The reaction mixtures were subjected to SDS–PAGE,
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reaction mixtures were subjected to SDS–PAGE, followed by autoradiography or immuno
cells were treated with several caspase inhibitors (20 lM) and STS (1 lM) for 1 h. Cell lprotein. Mouse anti-GFP and anti-PARP Abs from Santa Cruz
Biotechnology (CA, USA), mouse anti-caspases-3 and -7 Abs from
Calbiochem, and mouse anti-tubulin and anti-His monoclonal
Abs from Sigma were purchased.
2.3. Plasmid construction and site-directed mutagenesis
To generate various pcDNA3His-eIF3g mutants constructs, full-
length or deletion fragments of the eIF3g cDNA were inserted into
the pcDNA3.1His vectors and GFP-fused eIF3g constructs were
generated using the pEGFPC2 vector, as previously reported [15].
Various point mutants of aspartic acid were generated by PCR
using site-directed mutant primers.
2.4. In vitro caspase-mediated substrate cleavage assay
35S-methionine (10 lCi, Perkin–Elmer Life Sciences, MA, USA)
and pcDNA3-eIF3g constructs were added to the TNT reticulocyte
lysate of an in vitro transcription and translation system (Promega,
WI, USA). Reticulocytes containing 35S-labeled proteins were
reacted with recombinant caspase-3 or -7 (Calbiochem) at 37 C.
After adding SDS-sample buffer and boiling, the lysates were
subjected to SDS–PAGE followed by autoradiography.
2.5. Transfection and immunoblotting
T24 cells were seeded in a 6-well plate one day prior to
transfection; the cells were then transiently transfected with theE
h)
asp    - 7      9       8         - 9       9      7       7
35S-eIF3g                         rHis-eIF3g 
D
EV
D
D
M
SO
IE
TD
LE
H
D
VA
D
+      +      +     +      +
-
+
-
-
α-eIF3g
α-Casp7
Inhibitors
STS
0    3     6 (h)
35S-eIF3g
35S-β-catenin35S-eIF3g
sp3
VD
-
-
+
-
+
+
+ -
-
+
-
+
+
93
25
35
49
DM
IETD          DEVD
α-His
p20
S
at 10 lg for 6–12 h or STS at 1 lM for 1 h. Cell lysates were subjected to SDS–PAGE,
lated, and recombinant caspase-3 (0.3 lg) was reacted with an 35S-eIF3g-containing
followed by autoradiography. b-Catenin was used as a positive substrate for caspase-
bated with recombinant caspase-7 (0.1–1 lg) for 3 h; Gas2 was used as a positive
ant His-eIF3g was incubated with recombinant caspase-7, -8, or -9 (0.5 lg). The
blotting. Arrowhead, cleaved eIF3g; arrows, 35S-labeled non-speciﬁc bands. (E) T24
ysates were subjected to SDS–PAGE, followed by immunoblotting.
3670 J.-T. Kim et al. / FEBS Letters 587 (2013) 3668–3674indicated plasmids using the Lipofectamine 2000 reagent (Invitro-
gen, CA, USA) according to the manufacturer’s instructions. For
immunoblotting, the cells were lysed with CelLytic M buffer (Sig-
ma) and lysates were subjected to SDS–PAGE and transferred to
PVDF membranes. The membranes were blocked with 5% skim
milk and then incubated with Abs.
2.6. Fluorescent assay
Cells were transfected with pEGFPC2 for 6 h and then treated
with CDDP for 24 h. The cells were harvested, and the lysates
were transferred to a 96-well plate. The ﬂuorescent intensity
was measured using a ﬂuorometer (FilterMax F3, Molecular De-
vices, CA, USA) at 488/507 nm. For caspase-3 activity, cells were
transfected with pcDNA3His-eIF3g constructs and treated with
CDDP the next day. The cells were lysed, and ac-DEVD-amc
was added. Fluorescence was measured at 380/450 nm
according to the manufacturer’s instructions (Cell Signaling,
MA, USA).
2.7. Laser-scanning confocal microscopy
T24 cells grown on coverslips were transfected with the
pEGFPC2-eIF3g construct. The cells were washed, ﬁxed with 4%
paraformaldehyde, and permeabilized with 0.1% Triton X-100.
After washing, the cells were blocked with 1% BSA and incubated
with an anti-karyopherin Ab. The nuclei were stained with DAPI
(Sigma), and the cells were visualized using a confocal microscope
(LSM510META, Carl Zeiss, Germany).DEVD 
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transfected with pcDNA3His-eIF3g or eIF3g-N220. One day later, cells were treated with2.8. Statistics
The quantitative data are presented as the means ± S.D. Statisti-
cal signiﬁcance was assessed by a two-tailed unpaired Student’s t
test. P-values <0.05 were considered signiﬁcant.
3. Results
3.1. eIF3g is cleaved during apoptosis
Previously, we reported that AIF, a mitochondrial apoptotic pro-
tein, interacts with eIF3g and inhibits protein synthesis. Interest-
ingly, we found that eIF3g was cleaved when Jurkat or T24 cells
were treated with CDDP, a DNA chelating agent. As shown in
Fig. 1A, eIF3g and eIF3j were clearly cleaved in T24 cells, when
apoptosis induced by STS or CDDP treatment. Thus, we examined
which caspases were involved in the eIF3g cleavage during apopto-
sis. 35S-eIF3g protein was generated using an in vitro translation
system and incubated with recombinant caspases. eIF3g was spe-
ciﬁcally cleaved by caspase-3 and caspase-7 in a time- and dose-
dependent manner (Fig. 1B and C); b-catenin and Gas2, substrates
of caspase-3 and -7, respectively, were used as positive controls.
Furthermore, the speciﬁc caspase-3/7 inhibitor, z-DEVD-fmk,
blocked eIF3g cleavage, whereas dimethyl sulfoxide (DMSO) did
not, indicating that eIF3g might be a novel substrate of caspase-
3/7. We then investigated whether 35S-eIF3g or recombinant
His-eIF3g was also cleaved by initiator caspases (such as caspase-
8 and -9); as shown in Fig. 1D, eIF3g was cleaved by caspase-7
(indicated by an arrowhead), but not by caspase-8 or -9. To verify +      +     + 
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eletion mutants. One day later, the cells were treated with CDDP (lg) for 24 h. Cell
, H2O2 (1 mM, 6 h). (C) Cells were transfected with plasmids and treated with STS
with CDDP. Decreased expression of the proform (p32) of caspase-3 was detected in
n vitro translated and incubated with recombinant caspase-7 for 3 h. (F) Cells were
CDDP for 24 h, and the lysates were analyzed by immunoblotting.
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(caspase-3/7), z-VAD-fmk (pan-caspases), z-LEHD-fmk (caspase-
8), and z-IETD-fmk (caspase-9) were added prior to STS treatment.
We observed that eIF3g cleavage and caspase-7 activation were
blocked in the z-VAD and z-DEVD-treated cells, but were only
partially blocked in the z-LEHD and z-IETD-treated cells, indicating
that eIF3g is not a substrate of initiator caspases, such as caspase-8
and -9 (Fig. 1E).
3.2. eIF3g is cleaved at Asp220 by caspases
eIF3g consists of 320 amino acids (aa) and has a molecular
weight of 42–44 kDa. To delineate the cleavage site and the func-
tional domain, eIF3g was divided into N-terminal (N), middle
(M), and C-terminal (C) domains (Fig. 2A). When T24 cells were
transfected with pcDNA3His-eIF3g or its deletion mutants, eIF3g
and the variants, including -NM (1–229 aa), -M (75–229 aa), and
-MC (75–320 aa) were notably cleaved by CDDP treatment, with
cleavage of eIF3g-M and eIF3g-MC generating N-terminal products
of similar sizes (Fig. 2B). Furthermore, the cleavage products of
eIF3g and eIF3g-NM were similar in size with STS treatment
(Fig. 2C). These ﬁndings indicate that the cleavage site of eIF3g is
in the C-terminal region of the eIF3g-M fragment. Among several
XXXD sites, the SLRD220G motif represents an SXXD site that is re-
ported to be a recognition site for caspases [16,17]. We generated
an eIF3g-D220A mutant in which the Asp (D) residue is substituted
with Ala (A). When cells were transfected with pcDNA3His-eIF3g-
D220A and treated with CDDP, cleavage products were detectedeIF3gGFP
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Fig. 3. Nuclear translocation of the N-terminal fragment of eIF3g. (A) T24 cells grown on c
CDDP. The cells were ﬁxed and analyzed using confocal microscopy. (B) Cells were transf
analyzed by immunoblotting. (C) Cells grown on cover slips were transfected with pEGF
staining. (D) Cells were transfected with pEGFPC2-eIF3g, -DNLS, or -PYmut for 1 day and
with pEGFPC2-eIF3g variants, ﬁxed, stained, and analyzed using confocal microscopy. Ka
was evaluated. Cells in an area of 100  100 lm were scored. The mean ± S.D. values from
transfected with pEGFPC2-eIF3g or -DNLS; the nuclear and cytosolic fractions were isola
positive control for the nuclear fraction.for wild-type eIF3g and the eIF3g-D73/75A mutant (substitution
of Asp73 and Asp75) but not for the eIF3g-D220A mutant
(Fig. 2D), a result that was veriﬁed using recombinant caspase-7
and 35S-eIF3g-D220A (Fig. 2E). Overexpression of the eIF3g-N220
(1–220 aa) construct after transfection yielded similarly sized
eIF3g cleavage products (Fig. 2F), indicating that eIF3g is cleaved
at SLRD220 during apoptosis.
3.3. Nuclear translocation of the eIF3g N-terminus
Interestingly, we found that cytosolic eIF3g can translocate to
the nucleus during apoptosis. Cells were transfected with
pEGFPC2-eIF3g or the mutants and treated with CDDP, and the
cells were analyzed using confocal microscopy. In the GFP-eIF3g-
cells, cytosolic eIF3g was translocated to the nucleus when the
cells were treated with CDDP (Fig. 3A). However, cytosol-localized
GFP-eIF3g-D220A and nuclear-localized GFP-eIF3g-N220 remained
unchanged. To examine the cellular distribution of the eIF3g
fragments, several GFP-fused deletion mutants were generated,
and their expression was evaluated by immunoblotting (Fig. 3B).
Confocal microscopy showed the nuclear accumulation of the
M-region containing eIF3g-NM, -M, and -MC (Fig. 3C). This nuclear
translocation of eIF3g-M indicates that the M-region may contain
the nuclear localization sequence (NLS). To identify the predicted
NLS, two suspected regions were mutated: deletion of the basic
amino acid-rich region [D90–104 (DNLS)] and mutation of the
PY residue at 170–171 aa (PYmut). After eIF3g-DNLS and -PYmut
were assessed by immunoblotting (Fig. 3D), their cellulareIF3gNM eIF3g-CeIF3g-M eIF3gMC
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GFP-eIF3g-DNLS was distributed in the cytosol, whereas eIF3g
and eIF3g-PYmut were located in both the cytosol and nucleus.
As shown in Fig. 3F, the cells were scored as ‘‘nuclear’’ if the
nucleus exhibited a greater ﬂuorescence intensity than the
cytoplasm, and indeed the deletion of the putative NLS decreased
the translocation of eIF3g to the nucleus by one-third. We then
examined the distributions of GFP-eIF3g and -DNLS in the nucleus
versus the cytosol, and detected eIF3g-DNLS in the cytosolic
fraction (Fig. 3F).
3.4. The N-terminus of eIF3g indirectly activates caspases
Alterations in protein synthesis after CDDP treatment were
investigated. Newly synthesized proteins were found to be
strongly decreased, and eIF3g cleavage and caspase-3 activation
were observed, depending on the CDDP treatment (data not
shown). When cells were cotransfected with eIF3g-siRNA and
GFP plasmid, GFP protein synthesis was decreased with eIF3g
knockdown (Fig. 4A). In addition, the cells treated with eIF3g-siR-
NA showed cell growth retardation (Fig. 4B), indicating that eIF3g
is important for the translation system. To determine the role of
the eIF3g fragments, cells were transfected with eIF3g, -DNLS, -
M, -N220, or -C and treated with CDDP; cell lysates were reacted
with ac-DEVD-amc, a ﬂuorogenic substrate for caspase-3, and ﬂuo-
rescence was measured (Fig. 4C). Interestingly, NLS-containing
eIF3g-M and -N220 showed increased caspase-3 activity, even in
the cells that were not treated with CDDP, whereas the caspase-3
activity in cells transfected with the vector control, eIF3g wt, -C,5 
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Fig. 4. The N-terminal region of eIF3g indirectly activates caspases. (A) Cells were cotran
was measured using a ﬂuorometer, and eIF3g expression was examined by immunobl
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pcDNA3His-eIF3g or several fragments and treated with CDDP (10 lg, 24 h). Cells we
ﬂuorometer. (E) Cells were transfected with pcDNA3His-eIF3g-N220, and the cell lysateor -DNLS was not signiﬁcantly different. Furthermore, caspase-3
and -7 were activated when the cells were transfected with
eIF3g-N220 (Fig. 4D) or eIF3g-NM (data not shown), indicating that
caspase-mediated eIF3g cleavage may participate in apoptotic
process. However, the recombinant eIF3g-N220 did not directly
activate recombinant caspase-3 or caspase-7 (data not shown).
These data suggest that the NLS-containing N-terminal region of
eIF3g may play a role in the nucleus during apoptosis.
3.5. DNase activity of the eIF3g N-terminus
Because it had been reported that eIF3g is able to bind to AIF,
which translocates to the nucleus and induces large-scale DNA
fragmentation [15], we investigated whether eIF3g has DNase
activity. To test this possibility, eIF3g protein was in vitro trans-
lated, and 35S-labeled eIF3g was reacted with genomic DNA
(gDNA). As shown in Fig. 5A, gDNA was remarkably degraded in
the 35S-eIF3g-reticulocyte assay in the presence of caspase-7, but
remained intact in the absence of caspase-7 or in the additional
presence of z-DEVD-fmk. To verify the DNase activity of cleaved
eIF3g, Escherichia coli BL21 (DE3) cells were transformed with
pET28a-eIF3g, -NM, or -N220, and protein expression was induced
with isopropyl b-D-1-thiogalactopyranoside (IPTG). Lysates of cells
were incubated with gDNA prior to protein puriﬁcation, and gDNA
was signiﬁcantly degraded in the lysates of the eIF3g-NM- and -
N220-expressing cells (Fig. 5B). The recombinant proteins were
also puriﬁed and reacted directly with gDNA, which was rapidly
degraded in the presence of eIF3g-NM but not eIF3g (Fig. 5C).
The degradation of gDNA by eIF3g-NM and -N220 occurred in ap20
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Fig. 5. DNase activity of the N-terminal region of eIF3g. (A) In vitro-translated eIF3g was incubated with recombinant caspase-7 and reacted with gDNA; the samples were
then electrophoresed and stained with ethidium bromide. (B) E. coli BL21 (DE3) cells were transformed with pET28a-eIF3g, -NM, or -N220, and IPTG was added for protein
induction. The cells were lysed, and 2–5 lg of protein was incubated with gDNA for 1 h. The nucleases EcoR I and EcoR V were used as positive controls. (C and D) The
recombinant eIF3g wt, -NM, and -N220 proteins were puriﬁed and directly reacted with gDNA for 4 h (C), or 5 lg of protein was reacted for different time intervals (D). (E)
pEG202LexA (10.2 kb) plasmids were directly reacted with the puriﬁed eIF3g wt or -N220. E. coli lysates were also used (/+ IPTG). Nucleases Bgl II and EcoR V were used as
positive controls.
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stronger than that observed for EcoR I DNase (Fig. 5D). Lastly, when
plasmid pEG202LexA (10.2 kb) was incubated with the puriﬁed
eIF3g-N220, the plasmid was not digested but just cut one time
(Fig. 5E). Together, although the exact mechanism remains unclear,
our results suggest that the NLS-containing N-terminus of eIF3g
possesses strong DNase activity.
4. Discussion
Caspases are prominent regulators in apoptosis and play roles
in initiating and executing the caspase cascade to dismantle the
cellular survival system, including the process of translation for
protein synthesis. During the execution phase of apoptosis, down-
stream effector caspases cleave a variety of substrate proteins that
are known to play important roles in cellular homeostasis, the
organization and maintenance of the cellular structure, and the
apoptotic process. Caspase-mediated proteolytic cleavage of
several translation factors typically yields characteristic cleaved
products. eIF3j is normally involved in bridging the 40S ribosomal
subunit and eIF3 [18], but cleaved eIF3j has an altered afﬁnity for
the eIF3–40S complex [13]. Indeed, the afﬁnity of eIF3j for the
40S subunit is signiﬁcantly reduced by the caspase-3-mediated
removal of 16 residues at the C-terminus, and the resulting
eIF3–40S complex is less stable and less efﬁcient in translation
[19]. As we demonstrated in this study, eIF3g was cleaved bycaspase-3 and -7 at a site near the RNA recognition motif (RRM)
domain, resulting in decreased protein synthesis. Although we
could not detect the RRM-containing C-terminal fragment of eIF3g,
the large N-terminus of eIF3g was clearly detected by autoradiog-
raphy and immunoblotting. Cleavage of eIF3g by executioner casp-
ases is predicted to signiﬁcantly contribute to the collapse of the
translation initiation machinery.
In general, protein synthesis is signiﬁcantly down-regulated
during apoptosis, and we found that cell growth was suppressed
and protein production signiﬁcantly decreased when T24 cells
were transfected with an siRNA targeting eIF3g (Fig. 4). In addition,
the eIF3g protein was constitutively expresssed in several cell
lines, including colon and gastric tumor cells (data not shown).
Interestingly, the nuclear-localized eIF3g N-terminus (-NM, -M,
and -N220) induced caspase activation and DNA degradation, thus
exhibiting apoptotic characteristics (Figs. 4 and 5). However,
Machuy et al. [20] used RNAi screening for apoptosis regulators
and observed the inhibition of apoptosis via RNAi-induced eIF3g
suppression. Although they showed a contrasting and intriguing
result for eIF3g, eIF3g is clearly one of the core subunits of the
eIF3 complex [4,8,21], which is essential for translation initiation
and cell growth; indeed, these core subunits are conserved in yeast
and mammals. We are currently planning experiments to investi-
gate the molecular mechanisms by which eIF3g-N220 but not
eIF3g is able to activate caspases and degrade DNA, and we are
focusing on determining potential binding partners in the nucleus.
3674 J.-T. Kim et al. / FEBS Letters 587 (2013) 3668–3674In conclusion, our study reveals a novel role of the eIF3g N-termi-
nus, the executioner caspase-mediated cleavage product, in the
translation initiation machinery and in DNA degradation.
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